TTM
$2.43
YoY change
-14.5%
5Y CAGR
-11.2%
Peak year (2000)
$19.34
Latest annual
$2.47
EPS (Diluted) history chart for AMERISAFE (AMSF) from 1995 to 2025
Latest: $2.47
EPS (Diluted) growth chart for AMERISAFE (AMSF) from 1995 to 2025
Latest: -14.5%
EPS (Diluted) history table for AMERISAFE (AMSF) from 1995 to 2025
| 2025 | $2.47 | -14.5% | −$0.42 | ||
| 2024 | $2.89 | -10.5% | −$0.34 | ||
| 2023 | $3.23 | +12.2% | +$0.35 | ||
| 2022 | $2.88 | -15.0% | −$0.51 | ||
| 2021 | $3.39 | -24.2% | −$1.08 | ||
| 2020 | $4.47 | -6.9% | −$0.33 | ||
| 2019 | $4.80 | +29.4% | +$1.09 | ||
| 2018 | $3.71 | +54.6% | +$1.31 | ||
| 2017 | $2.40 | -40.7% | −$1.65 | ||
| 2016 | $4.05 | +9.8% | +$0.36 | ||
| 2015 | $3.69 | +29.9% | +$0.85 | ||
| 2014 | $2.84 | +22.4% | +$0.52 | ||
| 2013 | $2.32 | +46.8% | +$0.74 | ||
| 2012 | $1.58 | +22.5% | +$0.29 | ||
| 2011 | $1.29 | -28.7% | −$0.52 | ||
| 2010 | $1.81 | -18.5% | −$0.41 | ||
| 2009 | $2.22 | +3.3% | +$0.07 | ||
| 2008 | $2.15 | -13.0% | −$0.32 | ||
| 2007 | $2.47 | +31.4% | +$0.59 | ||
| 2006 | $1.88 | -250.4% | +$3.13 | ||
| 2005 | −$1.25 | -158.4% | −$3.39 | ||
| 2004 | $2.14 | -125.0% | +$10.69 | ||
| 2003 | −$8.55 | -64.0% | +$15.17 | ||
| 2002 | −$23.72 | — | — | ||
| 2000 | $19.34 | — | — | ||
| 1995 | $0.42 | — | — |
- 2025$2.47-14.5%
- 2024$2.89-10.5%
- 2023$3.23+12.2%
- 2022$2.88-15.0%
- 2021$3.39-24.2%
- 2020$4.47-6.9%
- 2019$4.80+29.4%
- 2018$3.71+54.6%
- 2017$2.40-40.7%
- 2016$4.05+9.8%
- 2015$3.69+29.9%
- 2014$2.84+22.4%
- 2013$2.32+46.8%
- 2012$1.58+22.5%
- 2011$1.29-28.7%
- 2010$1.81-18.5%
- 2009$2.22+3.3%
- 2008$2.15-13.0%
- 2007$2.47+31.4%
- 2006$1.88-250.4%
- 2005−$1.25-158.4%
- 2004$2.14-125.0%
- 2003−$8.55-64.0%
- 2002−$23.72—
- 2000$19.34—
- 1995$0.42—
EPS (Diluted) values are taken from AMERISAFE's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at AMERISAFE (AMSF)
According to AMERISAFE's latest reported financial statements, the company's current diluted EPS (TTM) is $2.43. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, AMERISAFE (AMSF) diluted EPS totalled $2.47 – declined 14.5% year-over-year.
Across 2020–2025 (5 years), AMERISAFE diluted EPS produced a CAGR of -11.2% – with a net decline across the window.
AMERISAFE diluted EPS plunged from $19.34 in 2000 to $2.47 in 2025, a 87.2% drawdown.
Across the available history, diluted EPS reached its high of $19.34 in 2000 and its low of −$23.72 in 2002.
AMERISAFE EPS (Diluted) by Year
AMERISAFE EPS (Diluted) 2025: $2.47
AMERISAFE diluted EPS in 2025 was $2.47, declined 14.5% below 2024.
AMERISAFE EPS (Diluted) 2024: $2.89
2024's diluted EPS for AMERISAFE came in at $2.89, declined 10.5% below 2023.
AMERISAFE EPS (Diluted) 2023: $3.23
AMERISAFE posted diluted EPS of $3.23 in 2023, grew 12.2% from 2022.
AMERISAFE EPS (Diluted) 2022: $2.88
In 2022, AMERISAFE reported diluted EPS of $2.88, declined 15.0% below 2021.
AMERISAFE EPS (Diluted) 2021: $3.39
AMERISAFE diluted EPS in 2021 was $3.39.
See more financial history for AMERISAFE (AMSF). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Financial Services peers of AMERISAFE (AMSF), ranked by their latest diluted EPS
| $51.32 | |
| $31.04 | |
| $20.05 | |
| $16.52 | |
| $10.20 | |
| $10.20 | |
| $6.32 | |
| $3.82 |
- $51.32
- $20.05
- $16.52
- $10.20
- $10.20
- $6.32
Frequently asked questions
AMERISAFE (AMSF) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation